Search Results (18,208)

Background and Objectives: Currently, the development of local drug delivery systems for the treatment of cancer patients is a pressing issue. Such systems allow for the targeted delivery of anticancer drugs directly to the tumor site, ensuring prolonged drug release or reducing the risk of recurrence after tumor removal, minimizing the impact on healthy tissues and thereby reducing the overall toxic load on the body. This work is devoted to evaluating the prospects of using scaffolds based on low-modulus titanium Ti-15Mo alloy with a biomimetic coating as a platform for the local administration of the cytostatic drug cisplatin into the patient’s body. Methods: Porous coatings were obtained by plasma electrolytic oxidation in an aqueous solution of sodium phosphate and calcium acetate with the addition of various components. The influence of coating parameters on the corrosion resistance of samples and on the antiproliferative effect of cisplatin-loaded scaffolds was evaluated. Human K562 hemoblastosis, HT116 intestinal cancer, and SKOV3 ovarian cancer cell lines were used as cell models. Results: It was shown that the addition of sodium phosphate (the PS type electrolyte) provides the formation of a coating with a developed system of interconnected pores characterized by an attractive combination of parameters: high porosity (17%), high pore size (3.9 μm), and considerable thickness (17.4 μm). This coating demonstrated the best corrosion resistance in a Ringer solution as compared to the other tested states. In addition, the PS coating loaded with cisplatin exhibited a pronounced cytotoxic effect on cancer cells. This effect was attributed to its ability to fix cisplatin on the surface, which slows down its release into the extracellular environment, increasing the time of its action, thereby contributing to a more effective (by more than 3 times) suppression of tumor cell proliferation compared to the action of the standard form of the drug in the form of a solution when changing the growth medium and subsequent incubation for 48 h. Conclusions: PS scaffolds made of low-modulus titanium alloy Ti-15Mo with a biomimetic surface in an electrolyte based on an aqueous solution of sodium phosphate and calcium acetate with the addition of sodium silicate can be used as an advanced platform for the local delivery of the cytostatic drug cisplatin, which makes them promising for application in orthopedic oncology. Full article

Background/Objectives: Immediate implant placement in the esthetic zone can shorten treatment time but maintaining peri-implant soft tissue stability is challenging. Conventional multi-stage workflows require multiple visits and may disturb peri-implant tissues. Placing a definitive one-time abutment at surgery can preserve soft tissue contours by avoiding multiple abutment changes. This case report introduces a digital one-stage approach delivering a definitive zirconia crown with delayed occlusal veneering at surgery to streamline treatment and preserve tissue stability. Methods: A 60-year-old male with a failing maxillary canine underwent immediate implant placement using guided surgery. A customized healing abutment preserved the emergence profile for the definitive restoration. A zirconia crown with an occlusal cut-back was fabricated and delivered at surgery on the one-time abutment without occlusal contact. After 12 weeks, a ceramic overlay was bonded extraorally to the crown to restore the occlusal surface. Results: At 2-year follow-up, the implant exhibited stable bone and healthy peri-implant soft tissues, with no complications. The one-time approach preserved tissue contours by eliminating provisional stages, and delayed occlusal veneering provided excellent esthetic integration. The patient was satisfied with the immediate result and fewer visits. This one-stage approach required fewer interventions than conventional provisional workflows. Conclusions: Immediate implant placement with a one-time abutment and delayed occlusal loading preserved peri-implant tissue architecture and achieved excellent functional and esthetic outcomes at 2 years. This one-stage workflow is a tissue-preserving alternative to multi-stage protocols; further studies are needed to confirm its long-term efficacy. Full article

The use of herbal medicines has gained popularity, both in science and among the public, as a natural alternative for the treatment of numerous diseases, including type 2 diabetes. Objective: The objective of this study was to evaluate peri-implant and long bone biomechanics in type 2 diabetic animals, treated or not with Bauhinia forficata. Methods: Thirty-two rats were allocated into four groups: normoglycemic (NG), normoglycemic + Bauhinia forficata (NGBf), type 2 diabetes (T2D), and T2D + Bauhinia forficata (T2DBf). Diabetes was induced using a cafeteria diet and streptozotocin (35 mg/kg). Bauhinia forficata tea (50 g/L) was administered to the NGBf and T2DBf groups. After 14 days, titanium implants were installed in the tibial metaphysis of all animals. Biomechanical analysis (removal torque), computerized microtomography, three-point bending test, confocal microscopy, and real-time PCR were performed. The results were tabulated, and a statistical test was conducted with a significance level of 5%. Results: Bauhinia forficata significantly improved the weight and blood glucose levels of the animals. In terms of biomechanics and the microarchitecture of long bones, T2D did not impair bone metabolism, and the use of the therapy did not cause significant changes in the parameters evaluated. However, T2D promoted significant impairment in the structural, biomechanical, and molecular characteristics of the peri-implant repair process, and the use of Bauhinia forficata increased the parameters evaluated in T2DBf. Conclusions: Type 2 diabetes mellitus significantly compromises peri-implant bone repair, with no influence on the metabolism of long bones, and Bauhinia forficata acts positively on both the etiopathogenesis of the disease and the tissue response to bone repair. Full article

Background: Accurate digital transfer of implant positions is critical for the long-term success of full-arch prosthetic rehabilitation. Photogrammetry remains the benchmark for accuracy, but its high cost and complexity limit clinical adoption. Artificial intelligence (AI)-driven intraoral scanning protocols incorporating real-time library matching and irregular, individually coded scan bodies have been proposed as accessible alternatives to improve accuracy and reproducibility. Methods: This in vitro study evaluated the trueness and precision of a full-arch implant scanning workflow using an AI-assisted real-time library matching system in combination with irregular multi-geometry titanium scan bodies. A high-accuracy structured-light scanner served as the reference standard. Six implant positions (35, 33, 31, 41, 43, 45) were scanned across 20 datasets (n = 120). Mean surface deviations were calculated against the reference STL using CloudCompare v.2.14. and a two-way ANOVA (α = 0.05) in SPSS tested the effects of implant position and scan iteration. Results: The workflow achieved a mean deviation of 13.55 ± 9.70 μm (range 0.77–43.46 μm) across all positions. Anterior sites showed the lowest deviations (e.g., position 31: 3.95 μm; 45: 5.96 μm), while posterior sites exhibited higher deviations (e.g., position 43: 26.15 μm). No mean deviation exceeded 30 μm, and no individual measurement surpassed 45 μm. Implant position significantly affected accuracy (p < 0.001), whereas scan iteration did not (p > 0.05). Conclusions: Within the limitations of this in vitro model, an AI-assisted real-time library matching workflow used in conjunction with irregular multi-geometry scan bodies achieved accuracy levels well within clinically acceptable ranges for full-arch implant impressions. Although comparable to values reported for photogrammetry under laboratory conditions, clinical equivalence should not be assumed. Further in vivo validation is required to confirm performance under routine clinical conditions. Full article

Corrosion is a complex, surface-initiated process that demands nanoscale, real-time characterization to understand its initiation and propagation. Atomic force microscopy (AFM) and scanning Kelvin probe force microscopy (SKPFM) have emerged as powerful tools in corrosion science, enabling high-resolution imaging and electrochemical mapping under realistic conditions. This review, inspired by pioneering work at KTH by Professors Christofer Leygraf and Jinshan Pan, highlights advanced analytical strategies that extend the capabilities of AFM and SKPFM beyond traditional line-profile analysis. Techniques such as power spectral density (PSD) analysis, multimodal Gaussian histogram fitting, statistical roughness quantification, and deconvolution methods are discussed in the context of case studies on aluminum alloys, stainless steels, magnesium alloys, biomedical implants, and protective coatings. By integrating in situ imaging, electrochemical mapping, and statistical data processing, these approaches provide deeper insights into localized corrosion, micro-galvanic coupling, and surface reactivity. Future directions include coupling AFM-based methods with high-speed imaging, machine learning, and spectro-electrochemical techniques to accelerate the development of corrosion-resistant materials and enable probabilistic diagnostics of corrosion initiation susceptibility. Full article

Liquid crystal elastomers (LCEs), as a class of smart materials, have attracted significant attention across soft robotics, biomedical engineering, and intelligent devices because of their unique capabilities to undergo large, reversible, and anisotropic deformations under external stimuli. Over the years, fabrication methods have advanced from conventional molding and thin-film processing to additive manufacturing, with 4D printing emerging as a transformative approach by enabling time-dependent, programmable shape transformations. Among the available methods, direct ink writing (DIW) and vat photopolymerization are most widely adopted, with ink chemistry, rheology, curing, and printing parameters directly governing mesogen alignment and actuation performance. Recent advances in LCE actuators have demonstrated diverse functionalities in soft robotics, including bending, crawling, gripping, and sequential actuation, while biomedical applications span adaptive tissue scaffolds, wearable sensors, and patient-specific implants. This review discusses the conceptual distinction between 3D and 4D printing, compares different additive manufacturing techniques for LCE, and highlights emerging applications in the field of soft robotics and biomedical technologies. Despite rapid progress in LCE, challenges remain in biocompatibility, long-term durability and manufacturing scalability. Overall, innovations in 4D printing of LCEs underscores both the promise and the challenges of these materials, pointing toward their transformative role in enabling next-generation soft robotic and biomedical technologies. Full article

Silk fibroin (SF) has evolved from a traditional biopolymer to a leading regenerative medicine material. Its combination of mechanical strength, biocompatibility, tunable degradation, and molecular adaptability makes SF a unique matrix that is both bioactive and intelligent. Advances in hydrogel engineering have transformed SF from a passive scaffold into a smart, living hydrogel. These systems can instruct cell fate, sense microenvironmental signals, and deliver therapeutic signals as needed. By incorporating stem cells, progenitors, or engineered immune and microbial populations, SF hydrogels now serve as synthetic niches for organoid maturation and as adaptive implants for tissue regeneration. These platforms replicate extracellular matrix complexity and evolve with tissue, showing self-healing, shape-memory, and stimuli-responsive properties. Such features are redefining biomaterial–cell interactions. SF hydrogels are used for wound healing, musculoskeletal repair, neural and cardiac patches, and developing scalable organoid models for disease and drug research. Challenges remain in maintaining long-term cell viability, achieving clinical scalability, and meeting regulatory standards. This review explores how advances in SF engineering, synthetic biology, and organoid science are enabling SF-based smart living hydrogels in bridging the gap between research and clinical use. Full article

In recent years, the development of stretchable electronic devices with mechanical properties similar to those of human tissues has attracted increasing research interest in biomedical engineering, wearables, and other fields. These devices have demonstrated, and some other researchers have already shown, promising advancements towards applications that span from measurements of the disruption of model barrier tissues to wearable or implantable devices, soft robotics, and the development of flexible and stretchable batteries. For example, models of barrier tissues, consisting of two compartments separated by a porous membrane, have been used to measure their integrity as well as to investigate the passage of drugs, toxins, and cancer cells through these tissues. Some of these models include an elastomeric membrane which can be stretched to model processes such as breathing and gut peristalsis, while others include electrodes for real-time measurement of barrier tissue integrity. However, to date, microelectrodes have not been fabricated directly on a porous elastomeric membrane. Here, we present lithographically patterned gold electrodes on porous PDMS membranes that enable electronic sensing capabilities in addition to mechanical manipulation. These membranes are incorporated into vacuum-actuated devices which impart cyclic mechanical strain, and their suitability for electrical impedance measurements, even after 1000 stretching cycles under fluids similar to cell culture media, is demonstrated. In the future, we expect to use these electrodes to measure the disruption in model cell barriers as well as to dielectrophoretically trap cells in a region of interest for more rapid assembly of a model tissue. Other areas like wearables, robotics, and power sources will greatly benefit from the further development of this technology. Full article

Myotonic Dystrophy Type 1 (DM1) is a complex multisystemic genetic disorder caused by CTG repeat expansions in the DMPK gene, leading to RNA toxicity and widespread splicing defects. These splicing abnormalities affect multiple systems, including the respiratory, skeletal, cardiac, nervous, and endocrine systems, resulting in aggressive symptoms that significantly impact quality of life and survival. Cardiac complications are the second leading cause of deaths in DM1, after respiratory insufficiency. Current research is largely focused on understanding cardiac pathology in DM1. This review highlights recent advancements in the clinical and pathological characterization of DM1 cardiac involvement, preclinical models used to study cardiac dysfunction, and emerging therapeutic strategies that target the molecular basis of DM1. Promising approaches include RNA-targeting strategies such as antisense oligonucleotides (ASOs), gene-editing tools like CRISPR-Cas9, and small molecules that modulate RNA splicing. ASOs aim to reduce toxic RNA accumulation, CRISPR-based approaches aim to excise or correct the expanded CTG repeats, and repurposed small-molecule drugs, such as vorinostat, tideglusib, and metformin, could serve as potential therapeutic agents for DM1 patients with cardiac complications. Despite this progress, several challenges remain: the heterogeneity of cardiac manifestations, unpredictable and often silent progression of arrhythmias, limited therapeutic options beyond implantable cardioverter-defibrillator (ICD)/pacemaker implantations, and complex interplay with the multisystemic nature of DM1. More research and well-designed clinical trials are urgently needed to translate these promising strategies into effective treatments for DM1-associated cardiac disease. Here, we discuss the current knowledge in DM1 cardiac pathology and preclinical models as well as the benefits and pitfalls of the available therapeutic approaches. Full article

Implant-associated infections remain a major clinical challenge, often leading to implant failure, revision surgery, and increased healthcare burden. Systemic antibiotic administration is limited by poor local bioavailability and systemic side effects, highlighting the need for localized drug-delivery systems that can simultaneously support tissue integration and prevent bacterial colonization. This study aimed to develop and characterize a novel generation of chitosan membranes loaded with hydroxyapatite–clindamycin phosphate (CS/HA-CLY) for localized infection prevention at implantation sites. The composite membranes’ physicochemical characteristics were analyzed using ATR FT-IR, XPS, SEM, XRD, and contact angle measurements. Furthermore, the in vitro biomineralization potential was assessed employing the Taguchi method, while the in vitro release of clindamycin phosphate was examined through UV-Vis spectrophotometry. The CS/HA-CLY membranes exhibited improved wettability, drug release behavior, and biomineralization ability compared to neat CS. These results suggest that the developed composite membranes could successfully combine antibacterial efficacy and biocompatibility, supporting their potential as multifunctional biomaterials for preventing implant-related infections while promoting tissue integration. These findings provide a promising basis for further biological assays and in vitro evaluation. Full article

Nearly 10% of IVF patients experience repeated implantation failure (RIF). Although several meta-analyses report improved outcomes following peripheral blood mononuclear cell (PBMC) administration, the uterine mechanisms remain poorly understood. We first analyzed PBMC composition and cytokine secretion in a preliminary cohort (n = 18), followed by endometrial immune profiling in a larger cohort (n = 70) before and after PBMC treatment. Embryo transfer was performed in 41 women, enabling the assessment of associations between immune profiles and implantation success. Successful implantation occurred in 16 of 41 embryo transfers (39%). PBMCs were predominantly composed of lymphocytes (60.7%), with T helper cells as the predominant T cell subset (Th/cytT ratio 1.44). Cytokine assays confirmed secretion of TNF-α, IL-6, IL-4, and IL-10. C-reactive protein levels remained below the threshold for systemic inflammation and were unaffected by PBMC administration. In the full cohort, PBMC infusion significantly enriched stromal macrophages and T helper cells, reflected by higher Th/T, Th/MΦ, and Th/cytotoxic T cell ratios and a reduced cytotoxic T/T cell ratio (all p ≤ 0.001). Importantly, women with successful implantation exhibited a significantly higher macrophage/T cell ratio (1.15 vs. 0.74; p = 0.024). These findings suggest that PBMC administration reshapes the endometrial immune landscape and that the macrophage/T cell ratio may serve as a promising biomarker of treatment efficacy. Full article

Background/Objectives: Sodium glucose co-transporter 2 inhibitors (SGLT2is) improve outcomes in heart failure; however, data in left ventricular non-compaction cardiomyopathy (LVNC) patients are limited. We sought to analyze the clinical effects of the SGLT2is dapagliflozin and empagliflozin in patients with LVNC. Methods: Thirty consecutive LVNC patients diagnosed by CMR were prospectively enrolled. Clinical, biochemical and echocardiography data were obtained at the initiation of the SGLT2is and at the 12-month follow-up. All patients were on stable guideline-directed medical therapy. A response to SGLT2i therapy was defined as an improvement in LVEF ≥ 5% at 12 months. Results: Of the 30 enrolled patients, 25 were male, with a mean age of 49 ± 16 years and few comorbidities. Dapagliflozin 10 mg was prescribed to 23 patients and empagliflozin 10 mg to 7 patients. Five patients experiened an adverse event during follow-up (one sudden cardiac death; four heart transplantations or LVAD implantations). During follow-up, significant improvements were observed in LVEF (32.1 ± 6.9% vs. 43.5 ± 9.7%; p = 0.003), LVOT VTI (14.8 ± 6.5 cm vs. 17.6 ± 3.3 cm; p = 0.008), E/e′ (14.8 ± 4.7 vs. 10.0 ± 4.1; p < 0.001), and TAPSE (2.0 ± 0.4 cm vs. 2.3 ± 0.4 cm; p = 0.012). NT-proBNP levels decreased significantly (2025 ± 2198 pg/mL vs. 582 ± 803 pg/mL; p = 0.005). Eighteen patients responded favorably to SGLT2i therapy (Group A), whereas seven showed no significant LVEF improvement (Group B). The groups did not differ significantly in age, sex, baseline creatinine, or bilirubin. Compared to Group B, Group A had a smaller baseline LV end-diastolic diameter (6.3 ± 0.8 cm vs. 7.1 ± 0.9 cm; p = 0.025) and lower NT-proBNP levels (1720 ± 1662 pg/mL vs. 4527 ± 4397 pg/mL; p = 0.02). Conclusions: In patients with LVNC, SGLT2i therapy is associated with significant reverse remodeling and functional improvement. Benefits may be greater in those with less advanced disease. Full article

Implantable technologies targeting the cerebral cortex and deeper brain structures are increasingly utilised in human–machine interfacing, advanced neuroprosthetics, and clinical interventions for neurological conditions. These systems require highly efficient and low-power methods for exchanging information between the implant and external electronics. Traditional approaches often rely on inductively coupled data transfer (ic-DT), where the same coils used for wireless power are modulated for communication. Other designs use high-frequency antenna-based radio systems, typically operating in the 401–406 MHz MedRadio band or the 2.4 GHz ISM band. A promising alternative is intrabody communication (IBC), which leverages the bioelectrical characteristics of body tissue to enable signal propagation. This work presents a theoretical investigation into two schemes—inductive coupling and galvanically coupled IBC (gc-IBC)—as applied to cortical data links, considering frequencies from 1 to 10 MHz and implant depths of up to 7 cm. We propose a hybrid solution where gc-IBC supports data transmission and inductive coupling facilitates wireless power delivery. Our findings indicate that gc-IBC can accommodate wider bandwidths than ic-DT and offers significantly reduced path loss, approximately 20 dB lower than those of conventional RF-based antenna systems. Full article

Three-dimensional printing has been progressively integrated into various industries, particularly the medical sector, where its significance in tissue engineering for transplantation is growing exponentially. The purpose of this systematic review is to ascertain whether the bioprinting of scaffolds holds the potential to provide treatment for pathologies within the female reproductive system. The inclusion criteria applied were the bioimprinting of the ovary, uterus, endometrium, or vagina, intended for surgical implantation in the patient. Articles employing printing methods that do not incorporate cells embedded in the material, those that generate tissue other than that of the female reproductive system, and those that print structures with in vitro applications were excluded from the review. The search for relevant articles was conducted until 3 April 2025. After analyzing 667 articles extracted from PubMed, Scopus and Web of Science, 13 articles were included in this review. The analysis of the results encompassed aspects related to the bioprinting technology employed, the hydrogels and cells utilized, as well as the bioprinted structure and the corresponding target tissue. Few studies investigated the creation of a multicellular scaffold and in none of the cases was it implanted in a large animal model, only in murine and rabbit models. These articles reaffirm the feasibility of employing 3D bioprinting to fabricate tissues and functional organs in the present and future. This advancement will revolutionize the future demand for organs for transplantation. Full article

Within the field of assisted reproductive technologies (ARTs), embryologists regularly face the critical task of identifying embryos with the highest likelihood of implantation and survival. To help aid and standardize this practice, many embryo selection strategies have been developed to give the best chance of pregnancy success. Over the years, there has been a large increase in experimental studies conducted within this area of research. This increase has allowed for the formation of significant and plausible theories of embryo development, especially in cases where the most prominent factors seem identical. These advancements have both expanded the typical process of traditional treatments and have even paved the way for new techniques. The exact combination of all these relevant factors has not been fully elucidated into a single all-encompassing scheme for embryo decision. Morphological, genetic, and developmental indicators are well-studied individually, but the exact methods that should be prioritized in each scenario may change with respect to an individual patient. Deciding whether factors like age, egg quality, lifestyle choices, or previous medical history should alter methods of embryo ranking can result in conflict, especially in the case where a choice is being made between two similar embryos. This article reviews the conventional methods along with emerging technologies that provide the tools for embryologists to evaluate and rank embryos with high implantation potential (HIP). By showcasing these methods, including their respective benefits and drawbacks, this article provides information to allow clinicians to make effective decisions by integrating multiple approaches to embryo selection. Full article